The FastTRK Testing Program
Fast TRK is a clinical testing program for the diagnosis of NTRK gene fusions. Sponsored by Bayer, this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion.
As you navigate this site, you can:
Learn more about the FastTRK program and how to submit your sample for testing
Find out if Bayer can support NTRK gene fusion testing
Get information on NTRK gene fusions and who should be tested